Piramal Pharma Limited Expands Riverview, Michigan, Facility
12/10/2020
Company officials said the expansion of 25,000 square feet, which includes 8,500 square feet of production space, will be used for the development and manufacturing of Active Pharmaceutical Ingredients. It is expected that the expansion will add approximately twenty new hires to the site, bringing the total headcount to more than 180 employees.
Peter DeYoung, CEO, Piramal Pharma Solutions said, "Piramal Pharma Solutions' Riverview facility has a well-earned reputation as the preeminent leader in high potency APIs (HPAPIs), and this expansion is designed to ensure that we retain that position. It enables us to support our customers' immediate and long-term API needs, strengthens our presence in North America, and enhances our ability to serve patients around the world by delivering the best active ingredients in a timely manner."
With successful inspections by the US FDA and many European and Asian government agencies, PPS' Riverview facility has a stellar track record of regulatory compliance and is committed to maintaining the highest possible standards of environmental performance, health and safety, company officials said.
Most Read
-
-
Trends in Office and Industrial Parks
Q4 2020
-
The Future of the Workforce Is a “Better Normal”
Workforce Q4 2020
-
Another Look at Rural Economies
Q4 2020
-
Supply Chain Execs Respond as Pandemic Creates E-Commerce Surge
Q4 2020
-
Recruiting and Retaining Today’s Manufacturing Workforce
Workforce Q4 2020
-
2019 Leading Metro Locations: Pacific and South-Atlantic Metros Dominate the List
Q4 2019